Abstract
Estrogens are important for the development of the mammary gland and strongly associated with oncogenesis in this tissue. The biological effects of estrogens are mediated through the estrogen receptor (ER),3 a member of the nuclear receptor superfamily. The estrogen/ER signaling pathway plays a central role in mammary gland development, regulating the expression and activity of other growth factors and their receptors. The generation of the ER knockout (ERKO) mouse has made it possible to directly understand the contribution of ER in mammary development and has provided an unique opportunity to study estrogen action in carcinogenesis. A mammary oncogene (Wnt-1) was introduced into the ERKO background to determine if the absence of the ER would affect the development of tumors induced by oncogenic stimulation. The development, hyperplasia, and tumorigenesis in mammary glands from the ERKO/Wnt-1 mouse line are described. These studies provide the impetus to evaluate the effect of other oncogenes in mammary tumorigenesis in the absence of estrogen/ER signaling.
Similar content being viewed by others
REFERENCES
F. W. George and J. D. Wilson (1988). Sex determination and differentiation. In E. Knobil, J. D. Neil, L. L. Ewing, G. S. Greenwald, C. L. Markert, and D. W. Pfaff, (eds.), The Physiology of Reproduction, Raven Press, New York, pp. 3–26.
R. J. Auchus and S. A. W. Fuqua (1994). The estrogen receptor. In M. C. Sheppard and P. M. Stewart, (eds.), Bailliere's Clinical Endocrinology and Metabolism: Hormones, Enzymes, and Receptors, Bailliere Tindall, London, pp. 433–449.
D. R. Ciocca and L. M. Vargas Roig (1995). Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocrine Rev. 16:35–62.
M. J. Tsai and B. W. O'Malley (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63:451–486.
D. Metzger, S. Ali, J. M. Bornert, and P. Chambon (1995). Characterization of the aminoterminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J. Biol. Chem. 270:9535–9542.
K. B. Horwitz, T. A. Jackson, D. L. Bain, J. K. Richer, G. S. Takimoto, and L. Lung (1996). Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1167–1177.
J. A. Katzenellenbogen, B. W. O'Malley, and B. S. Kazenellenbogen (1996). Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell-and promoter-specific action of these hormones. Mol. Endocrinol. 10:119–131.
J. C. Barrett and T. Tsutsui (1996). Mechanisms of estrogenassociated carcinogenesis. In J. Huff, J. Boyd, and J. C. Barrett, (eds.), Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, Wiley-Liss, New York, pp. 105–111.
S. G. Hillier (1991). Introvarian steroid action. In R. B. Hochberg and F. Naftolin, (eds.), New Biology of Steroid Hormones, Raven Press, New York, pp. 227–234.
J. N. Kenney and R. B. Dickson (1996). Growth factor and sex steroid interactions in breast cancer. J. Mam. Gland Biol. Neoplasia 1:189–198.
G. D. Jahnke and J. C. Barrett (1996). Environmental causes and molecular biology of breast cancer: future research directions. In J. Huff, J. Boyd, and J. C. Barrett, (eds.), Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, Wiley-Liss, New York, pp. 455–469.
C. L. Smith, O. M. Conneely, and B. W. O'Malley (1995). Oestrogen receptor activation in the absence of ligand. Biochem. Soc. Trans. 23:935–939.
E. P. Smith, J. Boyd, G. R. Frank, H. Takahashi, R. M. Cohen, B. Specker, T. C. Williams, D. B. Lubahn, and K. S. Korach (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man [see comments]. N. Engl. J. Med. 331:1056–1061.
D. B. Lubahn, J. S. Moyer, T. S. Golding, J. F. Couse, K. S. Korach, and O. Smithies (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 90:11162–11166.
K. S. Korach (1994). Insights from the study of animals lacking functional estrogen receptor. Science 266:1524–1527.
J. F. Couse, S. W. Curtis, T. F. Washburn, J. Lindzey, T. S. Golding, D. B. Lubahn, O. Smithies, and K. S. Korach (1995). Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9:1441–1454.
J. F. Couse, V. L. Davis, and K. S. Korach (1996). Physiological findings from transgenic mouse models with altered levels of estrogen receptor expression. In E. J. Pavlik, (ed.), Estrogens, Progestins, and Their Antagonists, Volume 2, Birkhauser, Boston, pp. 69–98.
K. S. Korach, J. F. Couse, S. W. Curtis, T. F. Wasburn, J. K. Lindzey, K. S. Kimbro, E. M. Eddy, S. Migliaccio, S. M. Snedecker, D. B. Lubahn, D. W. Schomberg, and E. P. Smith (1996). Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Rec. Prog. Horm. Res. 51:159–188.
C. T. Teng, B. T. Pentecost, Y. H. Chen, R. R. Newbold, E. M. Eddy, and J. A. McLachlan (1989). Lactotransferrin gene expression in the mouse uterus and mammary gland. Endocrinology 124:992–999.
W. L. Kraus and B. S. Katzenellenbogen (1993). Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists. Endocrinology 132:2371–2379.
S. W. Curtis, T. Wasburn, S. Charles, R. DiAugustine, J. Lindzey, J. F. Couse, and K. S. Korach (1996). Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc. Acad. Natl. Sci. U.S.A. 93:12626–12630.
M. N. Patterson, M. J., McPhaul and I. A. Hughes (1994). Androgen insensitivity syndrome. In M. C. Sheppard and P. M. Stewart, (eds.), Bailliere's Clinical Endocrinology and Metabolism: Hormones, Enzymes and Receptors, Bailliere Tindall, London, pp. 379–404.
M. Hewison and J. L. H. O'Riordan (1994). Vitamin D resistance. In M. C. Sheppard and P. M. Stewart, (eds.), Bailliere's Clinical Endocrinology and Metabolism: Hormones, Enzymes and Receptors, Bailliere Tindall, London, pp. 305–315.
V. K. K. Chatterjee and P. Beck-Peccoz (1994). Thyroid hormone resistance. In M. C. Sheppard and P. M. Stewart, (eds.), Bailliere's Clinical Endocrinology and Metabolism: Hormones, Enzymes and Receptors, Bailliere Tindall, London, pp. 267–283.
I. H. Russo and J. Russo (1996). Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 104:938–967.
D. L. Kleinberg (1997). Early mammary development: growth hormone and IGF-1. J. Mam. Gland Biol. Neoplasia 2:49–57.
C. W. Daniel, G. B. Silberstein, and P. Strickland (1987). Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res. 47:6052–6057.
G. B. Silberstein, K. Van Horn, G. Shymala, and C. W. Daniel (1994). Esential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134:84–90.
R. B. Dickson and M. E. Lippman (1995). Growth factors in breast cancer. Endocrine. Rev. 16:559–589.
R. P. DiAugustine, R. G. Richards, and J. Sebastian (1997). EGF-related peptides and their receptors in mammary gland development. J. Mam. Gland Biol. Neoplasia 2:109–117.
D. M. Ignar Trowbridge, C. T. Teng, K. A. Ross, M. G. Parker, K. S. Korach, and J. A. McLachlan (1993). Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7:992–998.
R. J. Pietras, J. Arboleda, D. M. Reese, N. Wongvipat, M. D. Pegram, L. Ramos, C. M. Gorman, M. G. Parker, M. X. Sliwkowski, and D. J. Slamon (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435–2446.
D. M. Ignar-Trowbridge, M. Pimentel, M. G. Parker, J. A. McLachlan, and K. S. Korach (1996). Peptide growth factor-cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137:1735–1744.
S. Kato, H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, D. Metzger, and P. Chambon (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491–1494.
M. Saceda, C. Knabbe, R. B. Dickson, M. E. Lippman, D. Bronzart, R. L. Lindsay, M. Gottardis, and M. B. Martin (1991). Postranscriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13 acetate. J. Biol. Chem. 266:17809–17814.
S. Z. Haslam (1988). Acquisition of estrogen-dependent progesterone receptors by normal mouse mammary gland. Ontogeny of mammary progesterone receptors. J. Steroid Biochem. 31:9–13.
R. Das and B. K. Vonderhaar (1997). Prolactin as a mitogen in mammary cells. J. Mam. Gland Biol. Neoplasia 2: 29–39.
J. P. Lydon, F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. A. Montgomery Jr., G. Shymala, O. M. Conneely, and B. W. O'Malley (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:2266–2278.
C. J. Ormandy, A. Camus, J. Barra, D. Damotte, B. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, N. Binart, and P. A. Kelly (1997). Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11:167–178.
T. J. A. Key and M. C. Pike (1988). The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol. 24:29–43.
S. M. Snedecker and R. P. Diaugustine (1996). Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland. In J. Huff, J. Boyd, and J. C. Barrett, (eds.), Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, Wiley-Liss, New York, pp. 211–253.
C. G. Castles and S. A. W. Fuqua (1996). Alterations within the estrogen receptor in breast cancer. In J. R. Pasqualini and B. S. Katznellenbogen, (eds.), Hormone-Dependent Cancer, Marcel Dekker, Inc., New York, pp. 81–105.
E. A. Musgrove, R. Hui, K. J. E. Sweeney, C. K. W. Watts, and R. L. Sutherland (1996). Cyclins and breast cancer. J. Mam. Gland Biol. Neoplasia 1:153–162.
P. Sicinski, J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
T. C. Wang, R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671.
P. Sicinski and R. A. Weinberg (1997). A specific role for cyclin D1 in mammary gland development. J. Mam. Gland Biol. Neoplasia 2:335–342.
R. M. L. Zwijsen, E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, and R. J. A. M. Michalides (1997). CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405–415.
B. E. Nowakowski and R. A. Maurer (1994). Multiple Pit-1 binding sites facilitate estrogen responsiveness of the prolactin gene. Mol. Endocrinol. 8:1742–1749.
G. R. Cunha, P. Young, Y-K Hom, P. S. Cooke, J. A. Taylor, and D. B. Lubahn (1997). Mechanism of estrogen action in mesenchymal-epithelial interactions in the mammary gland. J. Mam. Gland Biol. Neoplasia 2:393–402.
K. M. Scully, A. S. Gleiberman, J. K. Lindzey, D. B. Lubahn, K. S. Korach, and M. G. Rosenfeld (1997). Role of estrogen receptor α in the anterior pituitary gland. Mol. Endocrinol. 11:674–681.
P. Godfrey, J. O. Rahal, W. G. Beamer, M. G. Copeland, N. A. Jenkins, and K. E. Mayo (1993). GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat. Genet. 4:227–232.
E. M. Keough and B. G. Wood (1979). Mammary gland development during pregnancy in the dwarf mouse mutant, little. Tissue Cell 11:773–780.
R. Nusse and H. E. Varmus (1992). Wnt genes. Cell 69:1073–1087.
R. Nusse, A. van Ooyen, D. Cox, Y. K. T. Fung and H. E. Varmus (1984). Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307:131–136.
B. J. Gavin and A. P. McMahon (1992). Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Mol. Cell. Biol. 12:2418–2423.
P. Bhanot, M. Brink, C. H. Samos, J.-C. Hsieh, Y. Wang, J. P. Macke, D. Andrew, J. Nathans, and R. Nusse (1996). A new member of the frizzled family from drosophila functions as a wingless receptor. Nature 382:225–230.
J. Behrens, J. P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier (1996). Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382:638–642.
T. Hunter (1997). Oncoprotein networks. Cell 88:333–346.
M. Peifer (1997). β-catenin as oncogene: the smoking gun. Science 275:1752–1753.
A. S. Tsukamoto, R. Grosschedl, R. C. Guzman, T. Parslow, and H. E. Varmus (1988). Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55:619–625.
G. R. Cunha and Y. K. Hom (1996). Role of mesenchyme-epithelial interactions in mammary gland development. J. Mam. Gland Biol. Neoplasia 1:21–35.
T.-P. Lin, R. C. Guzman, R. C. Osborn, G. Thordarson, and S. Nandi (1992). Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Cancer Res. 52:4413–4419.
W. P. Bocchinfuso, W. P. Hively, H. E. Varmus, and K. S. Korach (1997). Mammary gland development and tumorigenesis in Wnt-1 transgenic mice lacking the estrogen receptor. (in preparation).
G. G. J. M. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson and J.-A. Gustafsson (1996). Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:5925–5930.
J. F. Couse, J. K. Lindzey, J.-A. Gustafsson, and K. S. Korach (1997). Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) mRNA in the wild-type and ERa-knockout mouse. Endocrinology (in press).
K. S. Korach, V. L. Davis, S. W. Curtis, and W. P. Bocchinfuso (1997). Xenoestrogens and estrogen receptor action. In J. A. Thomas and H. D. Colby (eds.), Endocrine Toxicology, Taylor and Francis, Washington, pp. 181–211.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bocchinfuso, W.P., Korach, K.S. Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout Mice. J Mammary Gland Biol Neoplasia 2, 323–334 (1997). https://doi.org/10.1023/A:1026339111278
Issue Date:
DOI: https://doi.org/10.1023/A:1026339111278